1. Home
  2. LKSP vs ABOS Comparison

LKSP vs ABOS Comparison

Compare LKSP & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LKSP

Lake Superior Acquisition Corp. Class A Ordinary Shares

SELL

Current Price

$10.28

Market Cap

161.3M

Sector

N/A

ML Signal

SELL

Logo Acumen Pharmaceuticals Inc.

ABOS

Acumen Pharmaceuticals Inc.

HOLD

Current Price

$1.99

Market Cap

147.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LKSP
ABOS
Founded
2024
1996
Country
United States
United States
Employees
2
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
161.3M
147.5M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
LKSP
ABOS
Price
$10.28
$1.99
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $7.60
AVG Volume (30 Days)
69.5K
★ 545.3K
Earning Date
01-01-0001
10-26-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.09
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$114.22
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.89
$1.50
52 Week High
$10.30
$3.60

Technical Indicators

Market Signals
Indicator
LKSP
ABOS
Relative Strength Index (RSI) 69.08 43.66
Support Level $10.09 $1.62
Resistance Level N/A $2.77
Average True Range (ATR) 0.01 0.14
MACD -0.00 0.04
Stochastic Oscillator 66.67 68.18

Price Performance

Historical Comparison
LKSP
ABOS

About LKSP Lake Superior Acquisition Corp. Class A Ordinary Shares

Lake Superior Acquisition Corp is a blank check company.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.

Share on Social Networks: